RxDoctor Payments Data

Lenora Debord, APRN

Psychiatric/Mental Health · Somerset, KYNPI 1801189261

Payments from drug & device makers

$1,004in general payments, 2019–2025

Across 61 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$225
  • Johnson & Johnson$198
  • Otsuka America Pharmaceutical, Inc.$195
  • Alkermes, Inc.$87
  • Vanda Pharmaceuticals Inc.$61
  • Teva Pharmaceuticals USA, Inc.$54
  • plus $184 from 5 others

What the payments were for

  • Food & beverage$1,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,004 in reported general payments places this provider in the 55th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$7,941
Medicare patients
34
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate23$94,231
TrintellixVortioxetine Hydrobromide47$25,728
RexultiBrexpiprazole13$18,825
Aripiprazole131$8,401
Divalproex Sodium113$4,065
Quetiapine Fumarate195$3,115
Divalproex Sodium ErDivalproex Sodium56$2,194
Duloxetine Hcl127$1,756
Olanzapine84$1,592
Thioridazine Hcl29$1,481
Haloperidol Decanoate19$1,420
Buspirone Hcl132$1,362
Haloperidol18$1,064
Clozapine38$1,050
Sertraline Hcl138$925

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$198$94,23123 claims
Otsuka America Pharmaceutical, Inc.Rexulti$195$18,82513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Somerset

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →